Community-Based Interventions to Address Disparities in Cardiometabolic Diseases Among Minoritized Racial and Ethnic Groups

Thomas, Victoria; Metlock, Faith; Hines, Anika L; Commodore‐Mensah, Yvonne; Brewer, LaPrincess C

doi:10.1007/s11883-023-01119-w

Cited by 8 publications

(2 citation statements)

References 73 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As noted, building trust with the research team can be accomplished through relationship building. The research team of the Black Impact study capitalized on its existing partnership with a trusted community organization to build initial interest in Black Impact, a tactic that has been successful in other settings [40,41]. Engaging key stakeholders was a critical component of community engagement, given that focusing solely on clinical trial recruitment without any input or cooperation from community members may have proven less successful [42].…”

Section: Discussionmentioning

confidence: 99%

More than Just a Number: Perspectives from Black Male Participants on Community-Based Interventions and Clinical Trials to Address Cardiovascular Health Disparities

Metlock,

Addison,

McKoy

et al. 2024

IJERPH

Self Cite

View full text Add to dashboard Cite

Background: Black Americans remain significantly underrepresented and understudied in research. Community-based interventions have been increasingly recognized as an effective model for reckoning with clinical trial participation challenges amongst underrepresented groups, yet a paucity of studies implement this approach. The present study sought to gain insight into Black male participants’ perception of clinical trials before and after participating in a community-based team lifestyle intervention in the United States. Methods: Black Impact, a 24-week community-based lifestyle intervention, applied the American Heart Association’s Life’s Simple 7 (LS7) framework to assess changes in the cardiovascular health of seventy-four Black male participants partaking in weekly team-based physical activities and LS7-themed education and having their social needs addressed. A subset of twenty participants completed an exit survey via one of three semi-structured focus groups aimed at understanding the feasibility of interventions, including their perceptions of participating in clinical trials. Data were transcribed verbatim and analyzed using a content analysis, which involved systematically identifying, coding, categorizing, and interpreting the primary patterns of the data. Results: The participants reported a positive change in their perceptions of clinical trials based on their experience with a community-based lifestyle intervention. Three prominent themes regarding their perceptions of clinical trials prior to the intervention were as follows: (1) History of medical abuse; (2) Lack of diversity amongst research teams and participants; and (3) A positive experience with racially concordant research teams. Three themes noted to influence changes in their perception of clinical trials based on their participation in Black Impact were as follows: (1) Building trust with the research team; (2) Increasing awareness about clinical trials; and (3) Motivating participation through community engagement efforts. Conclusions: Improved perceptions of participating in clinical trials were achieved after participation in a community-based intervention. This intervention may provide a framework by which to facilitate clinical trial participation among Black men, which must be made a priority so that Black men are “more than just a number” and no longer “receiving the short end of the stick”.

show abstract

Section: Discussionmentioning

confidence: 99%

More than Just a Number: Perspectives from Black Male Participants on Community-Based Interventions and Clinical Trials to Address Cardiovascular Health Disparities

Metlock,

Addison,

McKoy

et al. 2024

IJERPH

Self Cite

View full text Add to dashboard Cite

show abstract

“…There is growing evidence of the potential of community-based interventions to foster sustained partnerships for cardiovascular health promotion. However, support for these partnerships has been absent from most federal payment models and cross-sector partnerships with health care organizations are lacking . Future iterations of population health-based payment models should intentionally integrate referral programs to community-based resources and social needs services supplemented with incentive payments to facilitate synergistic risk reduction efforts with community organizations.…”

mentioning

confidence: 99%

Million Hearts Cardiovascular Disease Risk Reduction Model

Tajeu,

Joynt Maddox,

Brewer

2023

JAMA

Self Cite

View full text Add to dashboard Cite

Cardiovascular disease (CVD) is the leading cause of death in the US 1,2 and is responsible for extensive costs to the health care system. 2 Although CVD mortality rates declined over the past several decades in the US, this decline has recently stagnated. 1,3 Additionally, population-level increases in CVD risk factors and aging of the population threaten to further undermine progress. 1,2 Key clinical guideline recommendation changes to chronic CVD treatment have been implemented over the past 10 years aiming to lower atherosclerotic CVD (ASCVD) risk in the US. 4,5 In 2013, the American College of Cardiology/ American Heart Association recommended statin use for primary prevention of CVD among adults with a 10-year predicted ASCVD risk greater than or equal to 7.5% calculated using the pooled cohort equations. 4,6 In 2017, the American College of Cardiology/American Heart Association recommended reducing the blood pressure threshold for hypertension diagnoses and treatment from 140/90 mm Hg to 130/80 mm Hg. 5 However, guideline-recommended treatment goals at the population level have not been reached, and reductions in CVD rates are lagging.Given the need for innovative strategies to reduce population-wide CVD risk, the Centers for Medicare & Medicaid Services (CMS) has increasingly focused on using payment models as tools to drive quality improvement. In this issue of JAMA, Blue and colleagues report findings from one such model, the Million Hearts CVD Risk Reduction Model (Million Hearts Model) assessed in a pragmatic, clusterrandomized health services trial among 345 US health care organizations. 7 An initiative within the CMS and Centers for Disease Control and Prevention Million Hearts program, the Million Hearts Model was designed to reduce incident myocardial infarctions and strokes by incentivizing health care organizations to assess and lower 10-year ASCVD risk among Medicare beneficiaries. In addition to clinical targets, differences in Medicare spending on CVD events were assessed between intervention and control organizations.The Million Hearts Model study was conducted from 2017 to 2021 with beneficiaries entering the model from 2017 to 2018. Organizations participated voluntarily and were randomized to either an intervention or control group. Those randomized to the intervention group agreed to use the pooled cohort equations to calculate 10-year ASCVD risk among eligible Medicare beneficiaries (aged 40-79 y without established CVD, kidney failure, or hospice use). Direct compensation was provided for risk assessments, along with a risk reduction payment per beneficiary per month. In later study years, organizations received additional compensation

show abstract

Hypertension Management to Reduce Racial/Ethnic Disparities: Clinical and Community-Based Interventions

Turkson-Ocran,

Ogungbe,

Botchway

et al. 2024

Curr Cardiovasc Risk Rep

View full text Add to dashboard Cite

Community-Based Interventions to Address Disparities in Cardiometabolic Diseases Among Minoritized Racial and Ethnic Groups

Cited by 8 publications

References 73 publications

More than Just a Number: Perspectives from Black Male Participants on Community-Based Interventions and Clinical Trials to Address Cardiovascular Health Disparities

More than Just a Number: Perspectives from Black Male Participants on Community-Based Interventions and Clinical Trials to Address Cardiovascular Health Disparities

Million Hearts Cardiovascular Disease Risk Reduction Model

Hypertension Management to Reduce Racial/Ethnic Disparities: Clinical and Community-Based Interventions

Contact Info

Product

Resources

About